Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion type Assertion NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_head.
- NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion description "[Rat pretreatment with anti-PSGL-1 Ab prevented hepatic insult in a model of cold ischemia, followed by OLT, as assessed by 1) decreased hepatocellular damage (serum glutamic oxaloacetic transaminase/glutamic-pyruvic transaminase levels), and ameliorated histological features of ischemia/reperfusion injury, consistent with extended OLT survival; 2) reduced intrahepatic leukocyte infiltration, as evidenced by decreased expression of P-selectin, ED-1, CD3, and OX-62 cells; 3) inhibited expression of proinflammatory cytokine genes (TNF-alpha, IL-1beta, IL-6, IFN-gamma, and IL-2); and 4) prevented hepatic apoptosis accompanied by up-regulation of antiapoptotic Bcl-2/Bcl-xL protective genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_provenance.
- NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion evidence source_evidence_literature NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_provenance.
- NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion SIO_000772 16365457 NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_provenance.
- NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion wasDerivedFrom befree-20140225 NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_provenance.
- NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_assertion wasGeneratedBy ECO_0000203 NP872626.RAmKfM7_R_4mvq1oB2yztnno08vwDBc6L-Y_SY4k6r3z8130_provenance.